Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 2
2011 3
2012 4
2013 2
2015 1
2016 2
2017 4
2018 2
2019 2
2020 3
2021 4
2022 6
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Approach to asymptomatic creatine kinase elevation.
Moghadam-Kia S, Oddis CV, Aggarwal R. Moghadam-Kia S, et al. Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120. Cleve Clin J Med. 2016. PMID: 26760521 Free PMC article. Review.
Current and new targets for treating myositis.
Moghadam-Kia S, Oddis CV. Moghadam-Kia S, et al. Curr Opin Pharmacol. 2022 Aug;65:102257. doi: 10.1016/j.coph.2022.102257. Epub 2022 Jun 17. Curr Opin Pharmacol. 2022. PMID: 35724455 Review.
Anti-MDA5 Antibody Spectrum in Western World.
Moghadam-Kia S, Oddis CV, Aggarwal R. Moghadam-Kia S, et al. Curr Rheumatol Rep. 2018 Oct 31;20(12):78. doi: 10.1007/s11926-018-0798-1. Curr Rheumatol Rep. 2018. PMID: 30382445 Review.
Biologics for idiopathic inflammatory myopathies.
Moghadam-Kia S, Aggarwal R, Oddis CV. Moghadam-Kia S, et al. Curr Opin Rheumatol. 2017 Nov;29(6):645-651. doi: 10.1097/BOR.0000000000000432. Curr Opin Rheumatol. 2017. PMID: 28817464 Review.
Myositis in clinical practice-relevance of new antibodies.
Moghadam-Kia S, Aggarwal R, Oddis CV. Moghadam-Kia S, et al. Best Pract Res Clin Rheumatol. 2018 Dec;32(6):887-901. doi: 10.1016/j.berh.2019.03.012. Epub 2019 Apr 17. Best Pract Res Clin Rheumatol. 2018. PMID: 31427061 Review.
Risk Factors and Cancer Screening in Myositis.
Moghadam-Kia S, Oddis CV, Ascherman DP, Aggarwal R. Moghadam-Kia S, et al. Rheum Dis Clin North Am. 2020 Aug;46(3):565-576. doi: 10.1016/j.rdc.2020.05.006. Epub 2020 Jun 7. Rheum Dis Clin North Am. 2020. PMID: 32631604 Review.
Autoimmune disease and hair loss.
Moghadam-Kia S, Franks AG Jr. Moghadam-Kia S, et al. Dermatol Clin. 2013 Jan;31(1):75-91. doi: 10.1016/j.det.2012.08.008. Epub 2012 Oct 26. Dermatol Clin. 2013. PMID: 23159178 Review.
5th Global Conference on Myositis (GCOM).
Werth V, Wilfong EM, Mammen AL, Oddis CV, Saygin D, Liarski VM, Moghadam-Kia S, Aggarwal R, Ascherman DP. Werth V, et al. Among authors: moghadam kia s. Clin Exp Rheumatol. 2024 Feb;42(2):465-582. doi: 10.55563/clinexprheumatol/byxxv1. Epub 2024 Mar 11. Clin Exp Rheumatol. 2024. PMID: 38488100 Free article. No abstract available.
Treatment of female pattern hair loss.
Hassani M, Gorouhi F, Babakoohi S, Moghadam-Kia S, Firooz A. Hassani M, et al. Among authors: moghadam kia s. Skinmed. 2012 Jul-Aug;10(4):218-27. Skinmed. 2012. PMID: 23008939 Review.
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis.
Oddis CV, Rockette HE, Zhu L, Koontz DC, Lacomis D, Venturupalli S, Moghadam-Kia S, Ascherman DP, Crofford L, Dimachkie MM, Ernste F, Gazeley D, Marder G, Aggarwal R. Oddis CV, et al. Among authors: moghadam kia s. ACR Open Rheumatol. 2022 Nov;4(11):983-990. doi: 10.1002/acr2.11493. Epub 2022 Sep 20. ACR Open Rheumatol. 2022. PMID: 36128663 Free PMC article.
45 results